Latest Webinar
Want to discuss your research needs?
mRNA encoding OVA protein formulated in LNPs
NanOZ LNP Immunization is a ready-to-use mRNA encoding Ovalbumin (OVA), encapsulated in lipid nanoparticles (LNPs) produced by microfluidic technology.
The LNPs are monodisperse, with a narrow size distribution and a high encapsulation efficiency (>80%). They are designed to protect the mRNA from degradation and to facilitate its intracellular uptake.
The mRNA is modified with 5-methoxyuridine (5moU), capped at the 5' end (Cap1) and contains a poly(A) tail at the 3' end.
Concentration: 0.1 mg/mL (100 µg/mL) mRNA in LNPs
Buffer: PBS, 10% sucrose
Sizes:
This specific LNP formulation is also available with other mRNAs from the catalog, upon request.
Storage: -80°C. We recommend to minimize freeze-thaw cycles to preserve LNP integrity.
Shipping: Dry ice (dry ice fee included in shipping cost).
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNP10500MRNA41 |
0,5mL (2*250µL) of LNP-mRNA OVA
|
$750.00
|
|
| LNP11000MRNA41 |
1mL (4*250µL) of LNP-mRNA OVA
|
$1,319.00
|
|
| LNP15000MRNA41 |
5mL (20*250µL) of LNP-mRNA OVA
|
$5,063.00
|
|
| NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
| all cells | 0 | NanOZ LNP Immunization | Jeger-Madiot R. J Exp Med. 2024 Oct 7;221(10):e20240289. | |
| all cells | 0 | NanOZ LNP Immunization | Iemitsu K. J Lipid Res. 2025 Dec 5:100956. | |
| all cells | 0 | NanOZ LNP Immunization | Coleman HJ. J Pharm Sci. 2025 Nov 13;115(2):104066. | |
| all cells | 0 | NanOZ LNP Immunization | Jeger-Madiot R. J Exp Med. 2024 Oct 7;221(10):e20240289. |
Related products
mRNA encoding eGFP formulated in LNPs designed for in vitro transfection
mRNA encoding FLuc formulated in LNPs designed for liver delivery
Lipid Nanoparticles with SM-102 ionizable lipid available with GFP, FLuc...
mRNA encoding FLuc formulated in LNPs designed for spleen delivery
mRNA encoding FLuc formulated in LNPs designed for multiple organ...
mRNA encoding GFP formulated in LNPs designed for stem cells transfection